Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?
about
Cardiac origins of the postural orthostatic tachycardia syndromeCoronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyInfluence of endogenous angiotensin II on control of sympathetic nerve activity in human dehydration.Autonomic circulatory control during pregnancy in humans.Therapeutic strategies for targeting excessive central sympathetic activation in human hypertensionExaggerated sympathetic and pressor responses to handgrip exercise in older hypertensive humans: role of the muscle metaboreflex.The association of remotely-sensed outdoor temperature with blood pressure levels in REGARDS: a cross-sectional study of a large, national cohort of African-American and white participantsHeart rate recovery after maximal exercise is blunted in hypertensive seniors.Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapyThe baroreflex as a long-term controller of arterial pressure.Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients.Renal denervation for the treatment of resistant hypertension: review and clinical perspectiveCentral integration and neural control of blood pressure during the cold pressor test: a comparison between hydrochlorothiazide and aliskiren.Why is blood pressure so hard to control in patients with type 2 diabetes?Hypertension in rheumatoid arthritis.Central sympathetic overactivity: maladies and mechanisms.Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade.Neural and nonneural mechanisms for sex differences in elderly hypertension: can exercise training help?Sympathetic neural mechanisms in human cardiovascular health and disease.Sympathetic neural mechanisms in human blood pressure regulation.The sympathetic nervous system and blood pressure in humans: implications for hypertension.The baroreceptor as a therapeutic target for heart failure.Acute beetroot juice supplementation on sympathetic nerve activity: a randomized, double-blind, placebo-controlled proof-of-concept study.Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correFunctional sympatholysis is impaired in hypertensive humans.Chronic renin inhibition lowers blood pressure and reduces upright muscle sympathetic nerve activity in hypertensive seniors.Menstrual cycle effects on sympathetic neural responses to upright tilt.Exercise training attenuates increases in lumbar sympathetic nerve activity produced by stimulation of the rostral ventrolateral medulla.Intermittent hypobaric hypoxia exposure does not cause sustained alterations in autonomic control of blood pressure in young athletes.Prolonged Baroreflex Activation Abolishes Salt-Induced Hypertension After Reductions in Kidney Mass.Integrative Blood Pressure Response to Upright Tilt Post Renal Denervation.
P2860
Q24598057-39D3BB3E-1D53-413D-9007-C230D131AE75Q27026525-8ECB3A8C-F033-46F3-9E9E-DB8F97B5FFBAQ33157898-85B3551D-9564-4A23-88E2-16944E15E924Q33762529-B0D19394-ED3A-46B8-A168-6E03870E441CQ33805761-A83D93EC-B392-4AB3-8C3E-7C9C923A5729Q34357638-535D5083-3D59-469E-8747-DCA7DD4BA2CFQ34546983-1A6B32F2-79A3-4294-837C-D150DF4FAB25Q34626872-28C7DCDA-74F3-4E48-A28C-5CAAAC0942E2Q34904265-E0B1B32B-8E22-421E-B819-C6F3C9ED5EC3Q35138352-19C931B7-BCBF-40F8-814F-FBBD8CAFF6F6Q36106582-1B08DE0A-5100-4F18-81AE-6DF09E2FD844Q36122797-A0376679-23C1-48D3-84EF-C090CDFF6D0AQ36144508-224C6422-10E9-461A-8CD5-368E5CD93E0DQ36904456-E1E9BF65-C06E-495E-9AC9-052DD844A251Q37158219-A4E8E8C6-2850-4AE5-BABF-2F5C73022A93Q37186153-152E97CB-ECDD-48F2-8027-418E11AD3948Q37232970-E7F22271-9FE9-4F75-A375-8E3E05B46FDFQ37269607-1E840600-78D5-4F54-81EF-A82FE4D32EF7Q37327147-A453BE6E-EACA-4C24-A1B8-E6A39899030FQ37835754-2187E219-1C07-460F-BDD5-288C93437C8DQ37898511-B9A34AC7-1BE5-45CD-A356-6B9D5DCFF4A6Q38190492-F6A19D77-A8B8-45D7-92E7-CB5C142F5D2AQ38801296-F76DC932-61FE-4608-BB1C-D1AFF3EEA9A1Q41788525-26AEAC99-3060-4D31-9A3C-E801A4C73279Q45387746-07B602C3-1EA2-4FEA-B815-7CFC8842E66DQ46069490-F904B445-7129-422A-87F9-ABC2CC339E01Q46112155-0FA0E3A1-33EC-451D-8A61-CAF25B6C08EFQ48391886-B3655A54-9120-49B0-A6E4-8A5A390A59B2Q48481039-4D15DD26-FB06-4B74-AFF5-36E32AD82E84Q49742472-9637AD0C-278D-4DE2-A18E-8FA8CC5E85ADQ52887112-A102F0FF-F69B-4753-B46F-81D184F4100E
P2860
Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Persistent sympathetic activat ...... anism for long term morbidity?
@en
Persistent sympathetic activat ...... anism for long term morbidity?
@nl
type
label
Persistent sympathetic activat ...... anism for long term morbidity?
@en
Persistent sympathetic activat ...... anism for long term morbidity?
@nl
prefLabel
Persistent sympathetic activat ...... anism for long term morbidity?
@en
Persistent sympathetic activat ...... anism for long term morbidity?
@nl
P2093
P1433
P1476
Persistent sympathetic activat ...... anism for long term morbidity?
@en
P2093
Anand Prasad
Benjamin D Levine
Rong Zhang
Sarah Witkowski
P304
P356
10.1161/01.HYP.0000158312.63381.C1
P407
P577
2005-02-28T00:00:00Z